News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
695,508 Results
Type
Article (39541)
Company Profile (248)
Press Release (655719)
Section
Business (204104)
Career Advice (2007)
Deals (35414)
Drug Delivery (94)
Drug Development (80995)
Employer Resources (172)
FDA (16148)
Job Trends (14843)
News (345029)
Policy (32493)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2547)
Accelerated approval (2)
Adcomms (20)
Allergies (78)
Alliances (49364)
ALS (81)
Alzheimer's disease (1342)
Antibody-drug conjugate (ADC) (105)
Approvals (16142)
Artificial intelligence (224)
Autoimmune disease (13)
Automation (14)
Bankruptcy (360)
Best Places to Work (11639)
BIOSECURE Act (18)
Biosimilars (99)
Biotechnology (176)
Bladder cancer (56)
Brain cancer (24)
Breast cancer (244)
Cancer (1935)
Cardiovascular disease (146)
Career advice (1673)
Career pathing (29)
CAR-T (139)
Cell therapy (390)
Cervical cancer (16)
Clinical research (65606)
Collaboration (750)
Compensation (444)
Complete response letters (18)
COVID-19 (2579)
CRISPR (34)
C-suite (199)
Cystic fibrosis (98)
Data (1859)
Decentralized trials (2)
Denatured (15)
Depression (36)
Diabetes (241)
Diagnostics (6322)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (108)
Drug pricing (95)
Drug shortages (25)
Duchenne muscular dystrophy (81)
Earnings (86036)
Editorial (31)
Employer branding (21)
Employer resources (146)
Events (111516)
Executive appointments (626)
FDA (17216)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (677)
Gene editing (94)
Generative AI (18)
Gene therapy (269)
GLP-1 (676)
Government (4375)
Grass and pollen (4)
Guidances (48)
Healthcare (18800)
Huntington's disease (22)
IgA nephropathy (21)
Immunology and inflammation (100)
Indications (26)
Infectious disease (2705)
Inflammatory bowel disease (130)
Inflation Reduction Act (8)
Influenza (45)
Intellectual property (82)
Interviews (311)
IPO (16485)
IRA (40)
Job creations (3629)
Job search strategy (1422)
Kidney cancer (9)
Labor market (33)
Layoffs (446)
Leadership (15)
Legal (7900)
Liver cancer (70)
Lung cancer (279)
Lymphoma (128)
Machine learning (2)
Management (58)
Manufacturing (263)
MASH (58)
Medical device (13309)
Medtech (13314)
Mergers & acquisitions (19387)
Metabolic disorders (616)
Multiple sclerosis (67)
NASH (16)
Neurodegenerative disease (73)
Neuropsychiatric disorders (24)
Neuroscience (1800)
NextGen: Class of 2025 (6512)
Non-profit (4476)
Northern California (2355)
Now hiring (36)
Obesity (334)
Opinion (201)
Ovarian cancer (70)
Pain (75)
Pancreatic cancer (75)
Parkinson's disease (129)
Partnered (18)
Patents (196)
Patient recruitment (90)
Peanut (45)
People (57038)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20437)
Phase II (28894)
Phase III (21527)
Pipeline (908)
Podcasts (43)
Policy (107)
Postmarket research (2563)
Preclinical (8635)
Press Release (64)
Prostate cancer (90)
Psychedelics (30)
Radiopharmaceuticals (243)
Rare diseases (348)
Real estate (5901)
Recruiting (65)
Regulatory (22089)
Reports (46)
Research institute (2317)
Resumes & cover letters (349)
Rett syndrome (3)
RNA editing (2)
RSV (37)
Schizophrenia (61)
Series A (119)
Series B (76)
Service/supplier (11)
Sickle cell disease (49)
Southern California (2034)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (28)
Startups (3572)
State (2)
Stomach cancer (12)
Supply chain (59)
The Weekly (25)
United States (20641)
Vaccines (652)
Venture capitalists (37)
Webinars (12)
Weight loss (223)
Women's health (32)
Worklife (15)
Date
Today (147)
Last 7 days (576)
Last 30 days (2891)
Last 365 days (33682)
2025 (7359)
2024 (35219)
2023 (40077)
2022 (51173)
2021 (55713)
2020 (54085)
2019 (46541)
2018 (35026)
2017 (32115)
2016 (31491)
2015 (37558)
2014 (31319)
2013 (26346)
2012 (28571)
2011 (29264)
2010 (27329)
Location
Africa (717)
Alabama (49)
Alaska (7)
Arizona (221)
Arkansas (13)
Asia (37659)
Australia (6160)
California (5384)
Canada (1844)
China (454)
Colorado (239)
Connecticut (254)
Delaware (122)
Europe (80752)
Florida (798)
Georgia (188)
Idaho (57)
Illinois (482)
India (22)
Indiana (285)
Iowa (9)
Japan (134)
Kansas (99)
Kentucky (23)
Louisiana (7)
Maine (60)
Maryland (814)
Massachusetts (4055)
Michigan (208)
Minnesota (365)
Mississippi (2)
Missouri (75)
Montana (27)
Nebraska (25)
Nevada (56)
New Hampshire (62)
New Jersey (1526)
New Mexico (28)
New York (1550)
North Carolina (902)
North Dakota (7)
Northern California (2355)
Ohio (190)
Oklahoma (14)
Oregon (33)
Pennsylvania (1221)
Puerto Rico (9)
Rhode Island (25)
South America (1094)
South Carolina (17)
South Dakota (1)
Southern California (2034)
Tennessee (92)
Texas (797)
Utah (162)
Virginia (127)
Washington D.C. (57)
Washington State (505)
West Virginia (3)
Wisconsin (48)
695,508 Results for "23andme inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
23andMe Cuts Headcount by 40%, Drops Drug Discovery Work
In line with the restructuring initiative, 23andMe is looking for strategic opportunities for its pipeline assets, including licensing deals or outright sales.
November 12, 2024
·
2 min read
·
Tristan Manalac
Press Releases
23andMe Launches New Genetic Report on Osteoporosis
January 31, 2025
·
5 min read
Press Releases
23andMe Special Committee Announces Exploration of Strategic Alternatives
January 28, 2025
·
3 min read
Press Releases
23andMe Reports Third Quarter Fiscal Year 2025 Financial Results
January 28, 2025
·
19 min read
Biotech Bay
23andMe Launches New Genetic Report on Bipolar Disorder
23andMe Holding Co., a leading human genetics and biopharmaceutical company, released a new genetic Bipolar Disorder report for 23andMe+ Premium members, informing them if they are at higher likelihood for being diagnosed with the condition.
June 5, 2024
·
4 min read
Business
23andMe And Nightingale Health Announce Strategic Collaboration To Pilot Blood Biomarker Panel
23andMe Holding Co. and Nightingale Health Plc announced a strategic collaboration to pilot Nightingale Health’s clinically-validated and cost-effective blood metabolomics panel with a cohort of 23andMe members.
June 28, 2024
·
4 min read
Press Releases
23andMe Launches Discover23 to Help Accelerate Large-Scale Genetics Research For Biopharma Collaborators, Powered By Lifebit’s Trusted Technology
January 8, 2025
·
5 min read
Biotech Bay
23andMe announces CEO’s intention to pursue a potential take-private
23andMe Holding Co., a leading human genetics and biopharmaceutical company, has been made aware that Anne Wojcicki, Chief Executive Officer, Co-Founder, and Chair of the Board of Directors of 23andMe, is considering making a proposal to acquire all of the outstanding shares of 23andMe that she does not currently own, as she stated in an amendment dated April 17, 2024 to her Schedule 13D filing with the Securities and Exchange Commission.
April 18, 2024
·
3 min read
Drug Development
23andMe, Innate Pharma Tap Antibodies to Target NK Cells for Cancer
Drugmakers, including the genetic testing company 23andMe, are using novel approaches to stimulate NK cells’ intrinsic ability to recognize and kill tumor cells.
April 18, 2024
·
5 min read
·
Sunitha Chari
Biotech Bay
23andMe Launches New Genetic Reports on Common Forms of Cancer
23andMe Holding Co., a leading human genetics and biopharmaceutical company, released three new genetic reports for 23andMe+ members on breast, colorectal and prostate cancer.
March 6, 2024
·
6 min read
1 of 69,551
Next
